Company intelligence / Profile preview

Biose Industrie

Aurillac, Auvergne-Rhône-Alpes, Francebiose.com ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Biose Industrie does not develop its own therapeutics but serves as a world-leading CDMO specializing in the process development, scale-up, and GMP manufacture of live biotherapeutic products and next-generation probiotics for clients globally. The company supports projects from preclinical through commercial launch stages. It has demonstrated expertise in regulatory compliance with ANSM, EMA, FDA standards. Clinical results pertain to client programs manufactured by Biose.

Therapeutic areas: GastroenterologyMetabolic DisordersImmunologyWomen's Health
Modalities: Live biotherapeutic product therapyMicrobial therapyProbiotics (Next Generation Probiotics)Biologic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Biose Industrie.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biose Industrie.

Explore the full profile